James Huang, Director at Connect Biopharma Holdings Ltd (CNTB), bought 150,000 shares at $2.48 ($372K) on 2026-05-29, disclosed to the SEC on 2026-06-02.
Open-market purchase of $372k CNTB by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| ATRA | BUY | 2025-07-21 | $373K | — | Filing → |
| CASI | BUY | 2022-09-08 | $304K | — | Filing → |
| CASI | BUY | 2022-09-02 | $233K | — | Filing → |